Protagonist Therapeutics, Inc. (PTGX) has a market capitalization of $6.68B and trades at $104.72. The 52-week range is 39.6-107.84.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -51.1, Earnings Per Share (EPS) of $-2.05, annual revenue of $46.02M.
The stock has a beta of 2.11, operates in the Healthcare sector.
